Shane Maltbie
Finanzdirektor/CFO bei HILLEVAX, INC.
Vermögen: 1 Mio $ am 30.04.2024
Profil
Shane Maltbie is currently the Chief Financial Officer at HilleVax, Inc. He previously worked as the Director-Technical Accounting at PAREXEL International Corp.
from 2013 to 2015.
From 2019 to 2021, he served as the Vice President-Finance at TScan Therapeutics, Inc. Additionally, he held the position of Chief Accounting Officer & VP-Corporate Finance at Axcella Health, Inc. in 2019.
Mr. Maltbie completed his undergraduate degree at Hartwick College and his graduate degree at Northeastern University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
HILLEVAX, INC
0,18% | 08.02.2024 | 88 178 ( 0,18% ) | 1 Mio $ | 30.04.2024 |
Aktive Positionen von Shane Maltbie
| Unternehmen | Position | Beginn |
|---|---|---|
| HILLEVAX, INC. | Finanzdirektor/CFO | 06.01.2023 |
Ehemalige bekannte Positionen von Shane Maltbie
| Unternehmen | Position | Ende |
|---|---|---|
| TSCAN THERAPEUTICS, INC. | Corporate Officer/Principal | 01.12.2021 |
| AXCA HEALPAR | Comptroller/Controller/Auditor | 29.11.2019 |
| PAREXEL INTERNATIONAL CORPORATION | Corporate Officer/Principal | 01.10.2015 |
Ausbildung von Shane Maltbie
| Hartwick College | Undergraduate Degree |
| Northeastern University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| AXCA HEALPAR | Health Technology |
| TSCAN THERAPEUTICS, INC. | Health Technology |
| HILLEVAX, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
PAREXEL International Corp.
 PAREXEL International Corp. Miscellaneous Commercial ServicesCommercial Services PAREXEL International Corp. provides biopharmaceutical services. It offers clinical research and logistics, medical communications, consulting, commercialization and advanced technology products and services for pharmaceutical, biotechnology and medical device industries. The company was founded in 1983 and is headquartered in Newton, MA. | Commercial Services |
